Health ❯ Healthcare ❯ Pharmacology

Monoclonal Antibodies

Ocrelizumab INCA033989 Cetuximab CD20+ B Cells BAFF Pathway Mechanism of Action Zigakibart Nirsevimab Daratumumab Benralizumab

Single CAR T Infusion Clears Residual Disease in High-Risk Smoldering Myeloma Trial

Early, one-time CAR T shows promise to shift care for high-risk smoldering myeloma pending confirmation in larger trials.

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

FDA Grants Breakthrough Therapy Designation to Incyte’s CALR‑Targeting Antibody as ASH Data Show Early Efficacy in Myelofibrosis

Ocrelizumab Outperforms Rivals on MS Relapse Control in Real-World Study

Zigakibart sustains proteinuria remission and stabilizes kidney function over 100-week IgA nephropathy trial

Single Dose of Nirsevimab Halves Bronchiolitis Admissions in Infants Under Six Months

Avelumab and Cetuximab Combo Quadruples Progression-Free Survival in Advanced cSCC